X
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BORTEZOMIB, with a corresponding US DMF Number 30264.
Remarkably, this DMF maintains an Inactive status since its submission on March 01, 2016, highlighting commitment to regulatory compliance.